Citadel Advisors
VMD icon

Citadel Advisors’s Viemed Healthcare VMD Stock Holding History

Citadel Advisors’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-300
Closed -$2.18K – 15285
2025
Q1 		$2.18K Sell
300
-1,900
-86% -$14.9K ﹤0.01% 14058
2024
Q4 		$17.6K Sell
2,200
-200
-8% -$1.74K ﹤0.01% 13249
2024
Q3 		$17.6K Buy
2,400
+1,400
+140% +$10K ﹤0.01% 12877
2024
Q2 		$6.55K Sell
1,000
-2,300
-70% -$17.3K ﹤0.01% 13322
2024
Q1 		$31.1K Buy
3,300
+1,800
+120% +$15.4K ﹤0.01% 12667
2023
Q4 		$11.8K Buy
1,500
+800
+114% +$5.8K ﹤0.01% 13025
2023
Q3 		$4.71K Sell
700
-8,300
-92% -$68K ﹤0.01% 13460
2023
Q2 		$88K Sell
9,000
-2,800
-24% -$28.4K ﹤0.01% 11119
2023
Q1 		$114K Buy
11,800
+5,900
+100% +$51.4K ﹤0.01% 11073
2022
Q4 		$44.6K Buy
+5,900
New +$40K ﹤0.01% 12270

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Citadel Advisors's VMD Position: Q2 2026 in Review

Citadel Advisors increased its Viemed Healthcare (VMD) stake by 1,898% in Q2 2026, buying an estimated $2.2M and bringing the position to 234,315 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #5919.

Citadel Advisors first reported a position in VMD in Q3 2020 and has held it in 24 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Citadel Advisors held 234,315 shares of Viemed Healthcare worth $2.67M as of Q2 2026.
  • Citadel Advisors bought 222,585 Viemed Healthcare shares in Q2 2026, an estimated $2.2M.
  • Viemed Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5919 holding.
  • Citadel Advisors first reported a position in Viemed Healthcare in Q3 2020 and has held it in 24 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.